A Decade of Transformation in Genomics

SHENZHEN, China — MGI Tech Co., Ltd., a pioneer in life science innovation, proudly celebrates ten years of its groundbreaking DNBSEQ™ sequencing technology. Launched in 2015, DNBSEQ™ has reshaped the landscape of genomics by providing high-performance and cost-effective sequencing solutions to researchers and innovators worldwide.

Impact and Reach of DNBSEQ™ Technology

With over 3,900 installations globally and contributions to more than 10,900 peer-reviewed publications, DNBSEQ™ has earned its reputation as a cornerstone in advanced biomedical research. It plays a crucial role in various sectors, including precision medicine, public health, agriculture, and biodiversity, pushing the boundaries of what’s possible in genomic exploration.

Unmatched Speed and Precision

DNBSEQ™ boasts proprietary DNA nanoball technology, enabling unparalleled accuracy, reduced duplication rates, and minimal index hopping. This makes it suitable for a wide range of applications, from extensive genomic studies to sensitive clinical diagnostics. Recognized for its exceptional data quality, DNBSEQ™ is setting the gold standard in whole-genome and whole-exome sequencing.

A Diverse Portfolio for Every Need

MGI's DNBSEQ™ lineup includes a range of sequencers—from the ultra-high-throughput DNBSEQ-T20×2 that delivered a sub-$100 human genome to the compact DNBSEQ-E25 designed for fieldwork. The newest addition, the DNBSEQ-T1+, showcases MGI's commitment to innovation with a blend of power, speed, and flexibility.

Expanding Horizons with Multi-Omics

DNBSEQ™ goes beyond simple sequencing; it opens the door to multi-omics applications, including genomics, transcriptomics, and single-cell studies. Its versatility allows researchers to delve deeper into biological systems and disease mechanisms, making it invaluable across scientific disciplines.

Streamlined Scientific Processes

To enhance user experience, MGI provides a comprehensive suite of automation tools designed to facilitate an end-to-end workflow—from sample preparation to data analysis. This integrated approach allows researchers of all backgrounds to access advanced genomic technologies effortlessly.

Vision for the Future: The $10 Genome

Looking ahead, MGI sets its sights on achieving a groundbreaking target: the $10 genome. By building on the strengths of DNBSEQ™, MGI aims to further reduce costs, enhance accessibility, and accelerate research timelines.

A Mission to Democratize Genomics

MGI celebrates its decade-long journey with DNBSEQ™ not just as a technological triumph, but as a reaffirmation of its mission to make genomics accessible and impactful for everyone. By providing powerful tools for discovery, MGI is paving the way for a healthier, more informed world—one genome at a time.